10. Long-term treatment for ACS (Arabic Version)

How can you formulate a long-term plan for an ACS patient before hospital discharge & during follow-up at the OPD? 0:00 Intro 1:59 Cardiac Rehabilitation 3:36 Lifestyle Management 11:19 Pharmacotherapy 24:49 Adherence & Persistence 29:48 Imaging 30:32 Vaccination 31:26 Patient Perspectives 37:00 Finale 2023 ESC Guidelines for the Management of Acute Coronary Syndromes www.escardio.org/Guidelines/Clinical-Practice-Guid… 2023 ESC Guidelines for the management of acute coronary syndromes Supplementary data oup.silverchair-cdn.com/oup/backfile/Content_publi… 2021 ESC Guidelines of CVD Prevention www.escardio.org/Guidelines/Clinical-Practice-Guid… Playlist for the videos of 2021 ESC Guidelines of CVD Prevention (Arabic Version)    • Preamble to CVD Prevention Guidelines...   Playlist for the videos of 2021 ESC Guidelines of CVD Prevention (English Version)    • Preamble to CVD Prevention Guidelines...   2019 ESC Guidelines of Management of Chronic Coronary Syndromes www.escardio.org/Guidelines/Clinical-Practice-Guid… IMPROVE-IT trial. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes www.nejm.org/doi/full/10.1056/NEJMoa1410489 ODYSSEY OUTCOMES trial. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome www.nejm.org/doi/full/10.1056/NEJMoa1801174 REMINDER trial. Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure pubmed.ncbi.nlm.nih.gov/24780614/ EPHESUS trial. Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction www.nejm.org/doi/full/10.1056/NEJMoa030207 PARADISE-MI trial. Prospective ARNI versus ACE Inhibitor Trial to Determine Superiority in Reducing Heart Failure Events After MI. www.acc.org/Latest-in-Cardiology/Clinical-Trials/2… EMPAREG-OUTCOME trial. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes pubmed.ncbi.nlm.nih.gov/26378978/ CANVAS trial. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes www.nejm.org/doi/full/10.1056/NEJMoa1611925 DECLARE–TIMI 58. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes www.nejm.org/doi/full/10.1056/NEJMoa1812389 EMMY trial. Empagliflozin in acute myocardial infarction. academic.oup.com/eurheartj/article/43/41/4421/6677… SECURE trial. Polypill Strategy in Secondary Cardiovascular Prevention www.nejm.org/doi/full/10.1056/NEJMoa2208275